DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Welzel TM, Hinrichsen H, Sarrazin C. et al.
Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry.
J Viral Hepatitis 2017;
24: 840-849
We do not assume any responsibility for the contents of the web pages of other providers.